Clinical trial

LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction

NCT00887588

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention LCZ696 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Valsartan Normalized identity: valsartanView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-11-01

PhasePHASE2

Conditions

Chronic Heart Failureunresolved

Interventions

LCZ696DRUG

ValsartanDRUG · verified · RxNorm: valsartan

PlaceboDRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

MontrealQuebec, Canada2 MoscowRussia2 Saint PetersburgRussia2 WroclawPoland2 MadridMadrid, Spain2 HoustonTexas, United States1 ChicagoIllinois, United States1 NashvilleTennessee, United States1 Oklahoma CityOklahoma, United States1 DetroitMichigan, United States1 Little RockArkansas, United States1 AmsterdamNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00887588 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.